Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Change in Accured Expenses (2018 - 2025)

10x Genomics (TXG) has disclosed Change in Accured Expenses for 8 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 8.8% to $4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$5.2 million through Dec 2025, up 59.54% year-over-year, with the annual reading at -$5.2 million for FY2025, 59.54% up from the prior year.
  • Change in Accured Expenses hit $4.8 million in Q4 2025 for 10x Genomics, up from -$2.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $19.5 million in Q3 2023 to a low of -$12.7 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged $532650.0 across 5 years, with a median of $193000.0 in 2023.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 1192.3% in 2023 and later tumbled 7772.05% in 2024.
  • Year by year, Change in Accured Expenses stood at $1.7 million in 2021, then crashed by 204.84% to -$1.8 million in 2022, then surged by 1192.3% to $19.1 million in 2023, then plummeted by 77.03% to $4.4 million in 2024, then increased by 8.8% to $4.8 million in 2025.
  • Business Quant data shows Change in Accured Expenses for TXG at $4.8 million in Q4 2025, -$2.1 million in Q3 2025, and -$12.1 million in Q2 2025.